Ayurcann Holdings Corp Stock Fundamentals
| AYURF Stock | USD 0.02 0.03 57.69% |
Ayurcann Holdings Corp fundamentals help investors to digest information that contributes to Ayurcann Holdings' financial success or failures. It also enables traders to predict the movement of Ayurcann OTC Stock. The fundamental analysis module provides a way to measure Ayurcann Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ayurcann Holdings otc stock.
Ayurcann |
Ayurcann Holdings Corp OTC Stock Current Valuation Analysis
Ayurcann Holdings' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Ayurcann Holdings Current Valuation | 4.62 M |
Most of Ayurcann Holdings' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ayurcann Holdings Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Ayurcann Holdings Corp has a Current Valuation of 4.62 M. This is 99.97% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 99.97% higher than that of the company.
Ayurcann Holdings Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ayurcann Holdings's current stock value. Our valuation model uses many indicators to compare Ayurcann Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ayurcann Holdings competition to find correlations between indicators driving Ayurcann Holdings's intrinsic value. More Info.Ayurcann Holdings Corp is rated third in return on equity category among its peers. It is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ayurcann Holdings' earnings, one of the primary drivers of an investment's value.Ayurcann Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ayurcann Holdings' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Ayurcann Holdings could also be used in its relative valuation, which is a method of valuing Ayurcann Holdings by comparing valuation metrics of similar companies.Ayurcann Holdings is currently under evaluation in current valuation category among its peers.
Ayurcann Fundamentals
| Return On Equity | -0.71 | |||
| Return On Asset | -0.33 | |||
| Profit Margin | (0.43) % | |||
| Operating Margin | (0.46) % | |||
| Current Valuation | 4.62 M | |||
| Shares Outstanding | 155.56 M | |||
| Shares Owned By Insiders | 72.60 % | |||
| Price To Earning | 4.70 X | |||
| Price To Book | 1.00 X | |||
| Price To Sales | 0.50 X | |||
| Revenue | 11.08 M | |||
| Gross Profit | 2.22 M | |||
| EBITDA | (1.32 M) | |||
| Net Income | (3.09 M) | |||
| Cash And Equivalents | 1.24 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 40 K | |||
| Debt To Equity | 0.07 % | |||
| Current Ratio | 3.79 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (50.09 K) | |||
| Earnings Per Share | 0.01 X | |||
| Market Capitalization | 4.82 M | |||
| Total Asset | 7.28 M | |||
| Z Score | 73.0 | |||
| Net Asset | 7.28 M |
About Ayurcann Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ayurcann Holdings Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ayurcann Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ayurcann Holdings Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company was founded in 2018 and is headquartered in Pickering, Canada. Ayurcann Hldgs is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Ayurcann OTC Stock
Ayurcann Holdings financial ratios help investors to determine whether Ayurcann OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ayurcann with respect to the benefits of owning Ayurcann Holdings security.